Biosimilars have the potential to save the U.S. healthcare system $180B by the end of 2027, but bringing a biosimilar to patients not an easy journey. In fact, it can take 6-9 years and cost hundreds of millions of dollars.
Follow the journey here to see exactly what it takes: